VAERS reports by lot

Pfizer RSV lot HF5020: VAERS reports

22 VAERS reports list lot HF5020 as a Pfizer RSV vaccine, received between 2023-10-09 and 2024-09-20. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
14%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1226%
Injection-site / Local reaction817%
Neurological715%
Dermatological (non-injection-site)715%
Gastrointestinal613%
Cardiac / Cardiovascular37%
Allergic / Anaphylactic12%
Respiratory12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York5
Pennsylvania3
Massachusetts2
Kansas2
Wisconsin2
Minnesota1
Connecticut1
Oregon1
Washington1
District of Columbia1
Iowa1
Missouri1

Reports by month received

2023-108
2023-116
2023-122
2024-013
2024-021
2024-031
2024-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.